Clinical Trials Logo
  1. Home
  2. Pancreaticobiliary Cancer
  3. NCT02964806

Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients

Pancreaticobiliary Cancer Clinical Trial

Clinical Trial Summary

Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and oncologic outcomes negatively. Therefore it is important to improve nutritional status in postoperative period by supply tailor-made optimal diets. The investigators have developed customized postoperative diets for pancreaticobiliary cancer patients. The investigators expect that customized diets for pancreaticobiliary patients will increase the food intake rate and contribute a improvement of perioperative outcomes and even oncologic outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02964806
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date November 7, 2016
Completion date October 1, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03294096 - Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients N/A
Not yet recruiting NCT05171361 - Pancreaticogastrostomy Versus Pancreaticojejunostomy With Dunking Technique After Pancreaticodudenectomy: A Prospective Randomized Comparative Study
Recruiting NCT03510429 - Clinical Validation of Nutritional Supplements("Ketogenic Plus") Developed for Pancreaticobiliary Cancer Patients N/A